Related Experiment Video
Updated: Oct 5, 2025

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Acute Ischemic Stroke, Depressed Left Ventricular Ejection Fraction, and Sinus Rhythm: Prevalence and Practice
Anna D Baker1, Lee H Schwamm, Danita Y Sanborn2
1Department of Neurology (A.D.B., A.J., J.S., L.H.S., K.N.S., R.S.), Yale School of Medicine, New Haven, CT.
Nearly 5% of acute ischemic stroke patients have reduced ejection fraction and sinus rhythm. Antithrombotic treatment varies significantly by hospital and stroke severity, necessitating further research for optimal secondary prevention.
Area of Science:
- Cardiology
- Neurology
- Epidemiology
Background:
- Limited data exist on secondary stroke prevention for patients with acute ischemic stroke (AIS), depressed left ventricular ejection fraction (LVEF), and sinus rhythm.
- Understanding the prevalence of LVEF ≤40% and sinus rhythm in AIS patients is crucial for developing effective treatment strategies.
Purpose of the Study:
- To determine the prevalence of LVEF ≤40% and sinus rhythm in patients experiencing AIS.
- To describe antithrombotic treatment practices for this patient group in a multi-center cohort.
Main Methods:
- A multi-center, retrospective cohort study involving patients hospitalized with AIS.
- A meta-analysis of proportions was used to calculate pooled prevalence.
- Logistic regression identified factors associated with anticoagulant prescription at discharge.
Main Results:
- The pooled prevalence of LVEF ≤40% and sinus rhythm among AIS patients was 5.0%.
- Among eligible patients, 38% were discharged on anticoagulants, 55% on antiplatelet therapy only, and 7% on neither.
- Hospital site and stroke severity (NIHSS > 8) independently predicted anticoagulant use.
Conclusions:
- Approximately 5% of AIS patients present with reduced LVEF and sinus rhythm.
- Significant variations in antithrombotic therapy prescription exist across clinical sites and are influenced by stroke severity.
- Further research is required to establish optimal antithrombotic regimens for secondary stroke prevention in this population.
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Mitral Stenosis II: Clinical features and Diagnostic Tests

